Liraglutide
Showing 1 - 25 of 523
Polycystic Ovary Trial in Bani Suwayf (liraglutide, Metformin)
Not yet recruiting
- Polycystic Ovary
- liraglutide
- Metformin
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Jul 28, 2023
Polycystic Ovary Syndrome, Obesity, Infertility, Female Trial (Liraglutide + Metformin, Metformin)
Not yet recruiting
- Polycystic Ovary Syndrome
- +2 more
- Liraglutide + Metformin
- Metformin
- (no location specified)
Jul 10, 2023
Obesity, Childhood, Neural Development Trial in New Haven (Liraglutide)
Completed
- Obesity, Childhood
- Neural Development
- Liraglutide
-
New Haven, ConnecticutYale University
Dec 5, 2022
Type2 Diabetes, Coronary Artery Disease Trial in Miami (Liraglutide Pen Injector [Victoza], matching liraglutide- pre-filled
Recruiting
- Type2 Diabetes
- Coronary Artery Disease
- Liraglutide Pen Injector [Victoza]
- matching liraglutide-placebo pre-filled pens
-
Miami, FloridaUniversity of Miami
Nov 4, 2022
Parkinson Disease Trial in Los Angeles (Liraglutide, Placebo)
Completed
- Parkinson Disease
- Liraglutide
- Placebo
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Oct 27, 2022
Growth Hormone Deficiency, Healthy Trial in New York (growth hormone and lirglutide, growth hormone, liraglutide)
Not yet recruiting
- Growth Hormone Deficiency
- Healthy
- growth hormone and lirglutide
- +3 more
-
New York, New YorkNeuroendocrine Unit and Pituitary Center, Columbia University Ir
Dec 27, 2022
Obesity, Status Post Sleeve Gastrectomy Trial run by the NICHD (Liraglutide)
Recruiting
- Obesity
- Status Post Sleeve Gastrectomy
- Liraglutide
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 16, 2022
Type 1 Diabetes Trial in Kuwait City (drug, other, procedure)
Not yet recruiting
- Type 1 Diabetes
- Liraglutide / Semaglutide
- +4 more
-
Kuwait City, Al Asimah, KuwaitDasman Diabetes Institute
Jan 8, 2023
Diabetes, Type 1 Trial in Monterrey (Liraglutide)
Recruiting
- Diabetes Mellitus, Type 1
- Liraglutide
-
Monterrey, Nuevo León, MexicoCentro Médico Nacional del Noreste Hospital de Especialidades UM
Jul 19, 2022
Overweight AF Patients Following Ablation WithPotential Weight
Not yet recruiting
- Atrial Fibrillation
- +3 more
- Liraglutide plus upstream risk factors modification advice and consultation
- (no location specified)
Nov 1, 2022
Obesity Trial in Rochester (Liraglutide, Placebo)
Completed
- Obesity
- Liraglutide
- Placebo
-
Rochester, MinnesotaMayo Clinic in Rochester
May 27, 2022
Healthy Trial in Mannheim (BI 1820237, Placebo, Saxenda®)
Active, not recruiting
- Healthy
- BI 1820237
- +3 more
-
Mannheim, GermanyCRS Clinical Research Services Mannheim GmbH
Aug 10, 2022
Type 2 Diabetes Trial in Shanghai (Liraglutide injection,RD12014, Liraglutide injection,Victoza)
Completed
- Type 2 Diabetes
- Liraglutide injection,RD12014
- Liraglutide injection,Victoza
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Mar 16, 2022
Diabetes, Type 2 Trial in Palermo (Liraglutide injection, Insulin Glargine)
Completed
- Diabetes Mellitus, Type 2
- Liraglutide injection
- Insulin Glargine
-
Palermo, ItalyInternal Medicine Ward, University of Palermo
May 3, 2022
Morbid Obesity Trial in Alexandria (Liraglutide Pen Injector [Saxenda])
Not yet recruiting
- Morbid Obesity
- Liraglutide Pen Injector [Saxenda]
-
Alexandria, EgyptMadina Women's Hospital
Mar 9, 2022
Type 2 Diabetes Trial in Chongqing (Liraglutide, Oral antidiabetic drugs: Metformin, Sulfonylureas (2nd generation),
Completed
- Type 2 Diabetes Mellitus
- Liraglutide
- Oral antidiabetic drugs: Metformin, Sulfonylureas (2nd generation), Thiazolidinediones, α-Glucosidase inhibitors, and Glinides
-
Chongqing, Chongqing, ChinaThe third hospital affiliated to the Third Military Medical Univ
Apr 30, 2022
Obese, Overweight Trial in Shanghai (Liraglutide, Placebo)
Active, not recruiting
- Obese
- Overweight
- Liraglutide
- Placebo
-
Shanghai, ChinaZhongshan Hosital, Fudan University
Apr 16, 2022
Type 2 Diabetes Trial in Helsinki (Liraglutide, Placebo)
Completed
- Type 2 Diabetes
- Liraglutide
- Placebo
-
Helsinki, FinlandHelsinki University Central Hospital
Apr 11, 2022
Type 1 Diabetes Trial in Buffalo (Liraglutide)
Active, not recruiting
- Type 1 Diabetes
- Liraglutide
-
Buffalo, New YorkUBMD Pediatrics, Division of Pediatric Endocrinology
Mar 7, 2022
Type 2 Diabetes Treated With Insulin, Obesity, Adolescent Obesity Trial in Lahore (Dulaglutide, Liraglutide)
Completed
- Type 2 Diabetes Treated With Insulin
- +2 more
- Dulaglutide
- Liraglutide
-
Lahore, Punjab, PakistanZainab Khan
Mar 11, 2022
Bipolar Disorder, Obesity Trial in Mason (LIRAGLUTIDE, Placebo)
Active, not recruiting
- Bipolar Disorder
- Obesity
- LIRAGLUTIDE
- Placebo
-
Mason, OhioLindner Center of HOPE
May 24, 2022
Pouchitis, Irritable Pouch Syndrome Trial in Chapel Hill (Liraglutide Pen Injector, Placebo Pen Injector)
Recruiting
- Pouchitis
- Irritable Pouch Syndrome
- Liraglutide Pen Injector
- Placebo Pen Injector
-
Chapel Hill, North CarolinaUniversity of North Carolina
Mar 23, 2022
Obesity, Weight Loss Trial in Beirut (Dietary Intervention Med Diet, Dietary Intervention HP/LC Diet, Dietary Intervention LF
Recruiting
- Obesity
- Weight Loss
- Dietary Intervention Med Diet
- +2 more
-
Beirut, Riad El Solh, LebanonAmerican University of Beirut - Medical Center
Jul 19, 2022
Diabete Type 2 Trial (Liraglutide, Placebo)
Not yet recruiting
- Diabete Type 2
- Liraglutide
- Placebo
- (no location specified)
Feb 24, 2022